Related Experiment Video
Updated: Aug 24, 2025
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
[Primary hyperaldosteronism: indications for screening]
1National Medical Research Center of Cardiology.
Terapevticheskii Arkhiv
|October 26, 2022
Summary
Screening for primary hyperaldosteronism (PHA) is crucial for identifying a common cause of high blood pressure (hypertension). Early PHA detection and treatment can reduce cardiovascular risks associated with excess aldosterone.
Area of Science:
- Endocrinology
- Cardiology
- Hypertension Research
Context:
- Primary hyperaldosteronism (PHA) is an underdiagnosed cause of arterial hypertension (AH).
- Current screening practices for PHA in hypertensive patients are often inadequate.
- Methodological challenges hinder accurate PHA diagnosis and prevalence assessment.
Purpose:
- To review the current status of screening for primary hyperaldosteronism (PHA) in patients with arterial hypertension (AH).
- To analyze screening criteria and identify methodological errors impacting PHA diagnosis.
- To emphasize the need for improved PHA screening and diagnosis to manage uncontrolled AH.
Summary:
- This review examines the challenges and criteria for screening patients for primary hyperaldosteronism (PHA), a significant contributor to arterial hypertension (AH).
- It highlights low screening rates and discusses diagnostic pitfalls, advocating for better physician education on PHA detection.
- The analysis focuses on identifying high-risk AH populations for PHA development and assessing prevalence.
Impact:
- Improved screening and timely diagnosis of PHA can lead to targeted treatment.
- Effective management of PHA can reduce cardiovascular complications linked to aldosterone excess.
- Increased awareness and familiarization with PHA diagnostic methods are essential for managing resistant hypertension.
More Related Videos
Related Concept Videos
01:27Adrenal Gland Disorders
1.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.7K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
696
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
696
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
39
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
39
01:33Hormonal Regulation
33.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.6K
01:28Hypertension I: Introduction
49
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
49
01:25Antihypertensive Drugs: Direct Renin Inhibitors
762
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
762